Pancreatic alpha-amylase

 Pancreatic alpha-amylase

Human pancreatic amylase, also known as

pancreatic alpha-amylase, is an enzyme

primarily produced by the pancreas and

plays a crucial role in the digestion of

complex carbohydrates, such as starch and

glycogen, into simpler sugars like maltose

and glucose. Unlike human salivary alpha

44

amylase, which is secreted by the salivary glands and initiates the digestion of

starches in the mouth, pancreatic amylase works in the small intestine.

Pancreatic juice that contains a second α-amylase is released into the

duodenum when a meal is present in the digestive tract. Pancreatic amylase

continues the digestion of starch and glycogen in the small intestine. It is

produced in larger amounts than salivary amylase.

Location of Production: Human pancreatic amylase is synthesized and

secreted by the acinar cells of the pancreas. After its production, it is released

into the duodenum, the first part of the small intestine, to facilitate the

digestion of starches.

Digestive Function: The primary function of pancreatic amylase is to break

down complex carbohydrates into smaller units that can be easily absorbed by

the body. It hydrolyzes the alpha-1,4-glycosidic linkages in starch molecules,

leading to the formation of maltose, maltotriose, and alpha-limit dextrins.

pH and Optimal Conditions: Pancreatic amylase works optimally at a

slightly acidic to neutral pH range of about 6.7 to 7.0. This pH range is

typically found in the small intestine, where the enzyme can efficiently

perform its digestive function.

Regulation: The secretion of pancreatic amylase is regulated by hormonal

signals. Secretin, a hormone released by the small intestine in response to the

presence of acidic chyme (partially digested food), stimulates the pancreas to

release pancreatic enzymes, including amylase. Similarly, cholecystokinin

(CCK), another hormone released by the small intestine, also plays a role in

stimulating pancreatic enzyme secretion.

Clinical Significance: Measurement of pancreatic amylase levels in blood is

commonly used as a diagnostic tool for assessing pancreatic function and

diagnosing conditions such as acute pancreatitis. In cases of pancreatic

45

disorders or insufficient pancreatic function, the levels of pancreatic amylase

in the blood may be abnormal.

Structural Properties: Human pancreatic amylase is a glycoprotein, meaning

it has carbohydrate chains attached to its amino acid structure. The enzyme's

active site is formed by a catalytic cleft, which allows it to interact with starch

molecules and catalyze their hydrolysis.

Genetic Variants: Variations in the gene encoding pancreatic amylase,

AMY2B, have been reported to be associated with differences in starch

digestion efficiency among human populations. Some individuals may have

more copies of the gene, leading to higher amylase production and potentially

improved carbohydrate digestion.

The α-amylases from the two sources have similar catalytic properties, despite

having different amino acid sequences. They both require Cl− for optimum

activity and both act at neutral or slightly alkaline pH values.

Human salivary alpha-amylase plays a crucial role in the initial stages of

carbohydrate digestion and provides valuable insights into human dietary

adaptations and health conditions. Continued research in this area can deepen

our understanding of human biology and contribute to advancements in

medicine and nutrition22.